2023 Form 5500 filing — The Quest Diagnostics Profit Sharing Plan

Plain-English filing summary

According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20241010144655NAL0020361521001) for The Quest Diagnostics Profit Sharing Plan, reported by Quest Diagnostics Clinical Laboratories, Inc. under EIN 38-2084239 and plan number 333. It reports 61,840 participants. Attached schedules in the loaded dataset include Schedule H (large plan financials), Schedule C (service provider compensation).

EFAST2 acknowledgement
20241010144655NAL0020361521001
Filing year
2023
Form type
3
Plan sponsor
Quest Diagnostics Clinical Laboratories, Inc.
EIN
38-2084239
Plan number
333
Location
Secaucus, NJ
Participants
61,840
Schedules available
Schedule H, Schedule C
Received date
not reported in the loaded dataset

Reported financial snapshot (2023)

Total assets (EOY)
$5,126,995,000
Total liabilities (EOY)
$850,000
Net assets (EOY)
$5,126,145,000
Employer contributions
$98,792,000
Participant contributions
$202,692,000
Total income / additions
$1,087,623,000
Benefits paid
$567,375,000
Administrative expenses
$1,731,000
Total expenses
$569,106,000
Net increase / (decrease)
$518,517,000
Schedule source
Schedule H

Reported service provider compensation (Schedule C)

Compensation reported on the 2023 filing
ProviderServiceDirect comp.Indirect comp.
Fidelity Investments InstitutionalNONE$1,560,000$0
Aon Investments Usa IncNONE$160,000not reported in the loaded dataset
Grant Thornton LlpNONE$6,000not reported in the loaded dataset
Seyfarth Shaw LlpNONE$5,000not reported in the loaded dataset

Related Form 5500 pages